Bloomberg4:07 AM

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter.

Read original

More in this edition

10 stories

Older stories and past days

Browse saved daily editions in the public archive.

Browse past days